Anti-aging supplements lack proven benefits for longevity. That is the plain answer. No supplement has shown, in strong human trials, that it helps healthy people live longer.
The sales pitch often starts with a real detail. A compound may affect a cell pathway linked to aging. It may raise a blood marker. It may help an animal live longer. Then the claim grows. Soon, a small lab result becomes “supports longevity.”
That jump is the problem.
A mouse is not a person. A cell in a dish is not a human body. A change in a blood test is not proof of a longer life. These forms of evidence can help build a research idea. They cannot settle the question for consumers.
The strongest test is a randomized controlled trial. People are placed into different groups by chance. One group gets the compound. Another gets a comparison treatment. Researchers then measure outcomes that matter, such as illness, function, or death.
Those trials take time. Longevity is a slow outcome. A study lasting a few weeks cannot prove that a product adds years to life. It may show that the product changes a marker. That is a smaller claim.
This distinction matters with compounds such as NMN and NR. These products aim to raise NAD-related chemicals in the body. Some human studies show that they can change those levels. Reviews also report mixed or unclear results for health outcomes.
The marker can move while the person does not improve. That is not a contradiction. It means the marker may be part of the process, but it is not the final result.
The same issue appears with resveratrol. Early work made it sound like a powerful aging compound. Much of the excitement came from cells, animals, and proposed pathways. Human evidence has not shown that resveratrol extends life or clearly improves healthy lifespan.
Rapamycin and metformin raise a different concern. They are drugs, not ordinary wellness products. Researchers study them because they affect systems linked to aging. That makes them scientifically interesting. It does not make them proven longevity treatments for healthy people.
A proposed trial can be useful without proving the claim. Plans for large studies show that researchers still have questions. They do not show that the answer is already known.
Multivitamins offer a simpler lesson. A large study of older adults found no support for the idea that daily multivitamin use helps people live longer. The result did not turn vitamins into poison. It simply failed to support the longevity claim.
That is how evidence should work. A failed claim does not always prove harm. It may show no benefit. It may show a small benefit in one group. It may show that the study was too short. Each result needs its own wording.
Marketing rarely uses that wording.
A company may say a product “activates youth pathways.” That phrase may describe a lab finding. It does not tell us whether the product prevents disease or extends life. “Clinically studied” can mean that one small study measured a narrow marker. It does not mean the product has proven long-term value.
The word “natural” also proves very little. Natural substances can have strong effects. They can interact with drugs. They can affect blood pressure, bleeding, sleep, or blood sugar. Supplements can also vary in strength and purity.
Long-term safety is another weak spot. Many products have human studies that last weeks or months. Longevity claims concern years or decades. The time gap is large. A product that seems safe in a short trial may still have unknown risks with long use.
This does not mean every supplement is useless. Some supplements may help with a specific nutrient shortage or a defined health need. That is a different claim from “slows aging” or “helps people live longer.” The reason for use matters.
It also does not mean healthy aging research is fake. Aging biology is a real field. Scientists study inflammation, cell repair, energy use, and other systems. The field may produce useful treatments. The current evidence simply has not earned the broad promise made by many products.
The honest claim is smaller: some compounds show biological activity, and some may affect certain short-term outcomes. The larger claim, longer life for healthy people, remains unproven.
I judge these products by the size of the claim and the strength of the test. If a product changes a marker, the claim should stay near that marker. If an animal study suggests longer life, the claim should remain at the animal stage. If human trials show no clear benefit, the marketing should shrink.
That rule is not anti-science. It is pro-accuracy.
The main consumer red flag is a smooth chain of weak evidence. Watch for a product page that moves from cells to mice, from mice to people, and from people to “longevity” without showing a long human trial. Also watch for dramatic language built around small studies, surrogate markers, testimonials, or before-and-after stories.
One person’s routine cannot prove cause. A person may change diet, exercise, sleep, and many other habits at once. A good outcome may have several causes. A bad outcome may have several causes too. Testimonials are stories, not controlled evidence.
The main limit is clear. It is hard to study human lifespan directly. Researchers need large groups, long follow-up, and careful controls. Some products may help a narrow group or improve a health measure without extending life. Those questions remain open.
Open questions are not proof.
For now, anti-aging supplements belong in the category of promising ideas, not proven longevity tools. The evidence may improve. The claims may change. Until strong human trials show longer life or meaningful protection from major disease, the careful answer stays the same.
That is the kind of claim worth tracking: one that can grow when the evidence grows, and shrink when it does not. LifeX Signal follows the people, products, claims, and technologies shaping longer life, including the gap between what aging science finds and what marketing promises.
Explore: Supplements, Compounds and Claims